As of 2024-12-15, the Relative Valuation of Marinus Pharmaceuticals Inc (MRNS) is (68.29) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.26 USD, the upside of Marinus Pharmaceuticals Inc based on Relative Valuation is -26083.8%.
The range of the Relative Valuation is (63.39) - (74.33) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.0x - 29.2x | 26.6x |
| Forward P/E multiples | 24.9x - 29.2x | 27.0x |
| Fair Price | (63.39) - (74.33) | (68.29) |
| Upside | -24219.2% - -28384.3% | -26083.8% |
| Date | P/E |
| 2024-12-10 | -0.11 |
| 2024-12-09 | -0.12 |
| 2024-12-06 | -0.11 |
| 2024-12-05 | -0.11 |
| 2024-12-04 | -0.12 |
| 2024-12-03 | -0.12 |
| 2024-12-02 | -0.13 |
| 2024-11-29 | -0.13 |
| 2024-11-27 | -0.13 |
| 2024-11-26 | -0.13 |
| 2024-11-25 | -0.13 |
| 2024-11-22 | -0.13 |
| 2024-11-21 | -0.13 |
| 2024-11-20 | -0.12 |
| 2024-11-19 | -0.12 |
| 2024-11-18 | -0.12 |
| 2024-11-15 | -0.12 |
| 2024-11-14 | -0.12 |
| 2024-11-13 | -0.12 |
| 2024-11-12 | -0.14 |
| 2024-11-11 | -0.13 |
| 2024-11-08 | -0.14 |
| 2024-11-07 | -0.14 |
| 2024-11-06 | -0.13 |
| 2024-11-05 | -0.13 |
| 2024-11-04 | -0.13 |
| 2024-11-01 | -0.13 |
| 2024-10-31 | -0.12 |
| 2024-10-30 | -0.13 |
| 2024-10-29 | -0.11 |
| 2024-10-28 | -0.15 |
| 2024-10-25 | -0.16 |
| 2024-10-24 | -0.12 |
| 2024-10-23 | -0.66 |
| 2024-10-22 | -0.69 |
| 2024-10-21 | -0.71 |
| 2024-10-18 | -0.73 |
| 2024-10-17 | -0.68 |
| 2024-10-16 | -0.71 |
| 2024-10-15 | -0.68 |
| 2024-10-14 | -0.71 |
| 2024-10-11 | -0.69 |
| 2024-10-10 | -0.65 |
| 2024-10-09 | -0.67 |
| 2024-10-08 | -0.68 |
| 2024-10-07 | -0.73 |
| 2024-10-04 | -0.70 |
| 2024-10-03 | -0.68 |
| 2024-10-02 | -0.67 |
| 2024-10-01 | -0.66 |